Idorsia Ltd

Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.

IDIA | SW

Overview

Corporate Details

ISIN(s):: CH0363463438 (+2 more)
LEI:: 506700XOVZUB107S5720
Country:: Switzerland
Address:: Hegenheimermattweg 91, 4123 Allschwil
Website:: https://www.idorsia.com/index
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Idorsia Ltd is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines. The company focuses on building a diversified and balanced clinical development pipeline to transform therapeutic options for patients. Its research and development efforts target a range of conditions, with a primary focus on central nervous system (CNS), cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia aims to challenge existing medical paradigms by creating novel treatments that can significantly improve patient outcomes. The company also provides a dedicated portal with scientific information and educational resources for healthcare professionals and patients.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Idorsia Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Idorsia Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Idorsia Ltd via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
2022-05-11	N/A	Non-Executive member	Buy	None	98,179.90 CHF
2022-05-10	N/A	Non-Executive member	Buy	None	109,660.30 CHF

Peer Companies

Company	Country	Ticker
Labiana S.A. A pharmaceutical CDMO for sterile forms & manufacturer of veterinary and human medicines.	Spain	LAB
Labocanna Spolka Akcyjna Cultivates and distributes hemp products, medical marijuana, and private label natural cosmetics.	Poland	LCN
Labomar A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.	Italy	LBM
Laboratorio Farmaceutico Erfo Full-service contract manufacturer of nutraceuticals and food supplements for third-party brands.	Italy	ERFO
Laboratorio Reig Jofre S.A. Global pharma firm offering R&D, manufacturing, and marketing of injectables and supplements.	Spain	RJF
Laboratorios Farmaceuticos Rovi S.A. Develops & manufactures prescription drugs & provides third-party contract manufacturing.	Spain	ROVI
Lavipharm S.A. Develops and distributes pharmaceuticals and consumer health products using advanced delivery systems.	Greece	LAVI
Lonza Group AG A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.	Switzerland	LONN
MaaT Pharma Developing gut microbiome therapies to improve survival for cancer patients.	France	MAAT
Mabion S.A. Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.	Poland	MAB